| Primary |
| Asthma |
60.0% |
| Hypertension |
20.0% |
| Chronic Obstructive Pulmonary Disease |
10.0% |
| Copd |
10.0% |
|
| Nausea |
22.2% |
| Dizziness |
11.1% |
| Myalgia |
11.1% |
| No Therapeutic Response |
11.1% |
| Pharyngeal Oedema |
11.1% |
| Plicated Tongue |
11.1% |
| Rash Generalised |
11.1% |
| Tachycardia |
11.1% |
|
| Secondary |
| Asthma |
21.8% |
| Antiretroviral Therapy |
14.5% |
| Chronic Obstructive Pulmonary Disease |
10.9% |
| Pain |
7.3% |
| Product Used For Unknown Indication |
5.5% |
| Pulmonary Edema |
5.5% |
| Anaemia |
3.6% |
| Constipation |
3.6% |
| Diabetes Mellitus |
3.6% |
| Migraine |
3.6% |
| Osteoporosis |
3.6% |
| Bladder Disorder |
1.8% |
| Blood Cholesterol Abnormal |
1.8% |
| Blood Pressure |
1.8% |
| Cardiac Disorder |
1.8% |
| Cardiac Disorder Nos |
1.8% |
| Depression |
1.8% |
| Diabetes |
1.8% |
| Fluid Retention |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
|
| Aortic Dissection |
20.0% |
| Peripheral Ischaemia |
20.0% |
| Chronic Obstructive Pulmonary Disease |
10.0% |
| Herpes Simplex |
10.0% |
| Large Intestine Polyp |
10.0% |
| Pulmonary Oedema |
10.0% |
| Thrombocytopenia |
10.0% |
| Weight Decreased |
10.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.4% |
| Asthma |
14.7% |
| Drug Use For Unknown Indication |
6.3% |
| Breast Cancer |
5.3% |
| Pain |
5.0% |
| Antiviral Prophylaxis |
4.2% |
| Cardiac Failure |
4.2% |
| Multiple Myeloma |
4.2% |
| Prostate Cancer |
4.2% |
| Atrial Fibrillation |
3.9% |
| Premedication |
3.9% |
| Chronic Obstructive Pulmonary Disease |
3.7% |
| Depression |
3.5% |
| Hypertension |
3.3% |
| Rheumatoid Arthritis |
2.6% |
| Prophylaxis |
2.2% |
| Prostate Cancer Metastatic |
2.0% |
| Type I Diabetes Mellitus |
2.0% |
| Angioedema |
1.8% |
| Antiemetic Supportive Care |
1.8% |
|
| Human Chorionic Gonadotropin Increased |
15.9% |
| Blood Human Chorionic Gonadotropin Increased |
12.7% |
| Dyspnoea |
7.9% |
| Otitis Media |
6.3% |
| Renal Failure Acute |
6.3% |
| Death |
4.8% |
| Pneumonia |
4.8% |
| Atrial Fibrillation |
3.2% |
| Blood Glucose Increased |
3.2% |
| Cardiac Failure |
3.2% |
| Cervix Carcinoma |
3.2% |
| Convulsion |
3.2% |
| Delirium |
3.2% |
| Glomerular Filtration Rate Decreased |
3.2% |
| Hallucination |
3.2% |
| Liver Function Test Abnormal |
3.2% |
| Lung Neoplasm Malignant |
3.2% |
| Myocardial Infarction |
3.2% |
| Post Procedural Haemorrhage |
3.2% |
| Pseudomonal Sepsis |
3.2% |
|
